- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robert Hopkin on Future Considerations for Management of Fabry Disease
Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center, provides an overview of the evolving treatment landscape in Fabry disease.
With no treatment options for Fabry disease 20 years ago, there are now 2 treatments approved and several new options being investigated for use, said Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center.
Transcript
What are some future considerations regarding management of Fabry disease?
Fabry disease is a changing field constantly, and right now most of the patients who are being treated have very little enzyme production from the copy of the gene that's abnormal. So, in men, they only have 1 copy, and in women, they have 2 copies, but the cells with X inactivation, the cells that have the abnormal copy of the gene, usually don't make any and there's, for reasons we don't understand, not cross correction between the cells.
We need to pay attention to the treatment options. We've gone from no treatment 20 years ago to now we have 2 treatments, and there are probably at least 10 groups studying newer options to improve the outcome for people with Fabry disease.
So, scientifically, it's an exciting time. Probably in the next 5 to 10 years, we will have some treatments that are less of a burden on the patients. And I think that it behooves the medical care providers and the patients with Fabry disease to keep an eye on this evolution so that we can take advantage of what we're learning as the science advances.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
